NCT02004067 - Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Primary Sjogren SyndromeSecondary Sjogren SyndromeAqueous Deficient Dry Eye DiseaseEvaporative Dry Eye Disease

Interventions

DRUG

Restasis

Restasis is an ophthalmic emulsion containing cyclosporine 0.5 mg/mL, produced by Allergan Inc.

DRUG

Refresh Endura

Refresh Endura is a topical lubricant produced by Allergan, Inc.

Trial Locations (1)

Departamento de Oftalmologia da Escola Paulista de Medicina - UNIFESP, São Paulo